“…The prevalence of CRE, including CP-CRE, is high in the tertiary hospitals of the larger South Asian countries (10, 53, 62-71, 75, 82, 83, 99, 101, 102) but much lower in similar hospitals in Southeast Asia (74,114,120,121,129,134,142,147,149,150,157,161). As seen by the numerous reports of CP-CRE exportation from South and Southeast Asia (6,174,(176)(177)(178)(179)(180)(181)(182)(183)(184), international dissemination of CP-CRE appears to be a far greater problem than that of CRAB, and it will conceivably be more difficult for other countries to control CP-CRE within their own borders if this is also not tackled at its root in South and Southeast Asia.…”